Travere Therapeutics, Inc.
TVTX
50 insider filings · Latest: Jun 22, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | Feb 4 11:00 AM | Peter Heerma | Proposed Sale | 7,310 | $32.12 | $234.8K | — | View → |
| Feb 3, 2026 | Feb 4 2:59 AM | Elizabeth E. Reed | Proposed Sale | 7,175 | $32.12 | $230.5K | — | View → |
| Feb 3, 2026 | Feb 4 2:58 AM | Sandra Calvin | Proposed Sale | 4,333 | $32.12 | $139.2K | — | View → |
| Feb 3, 2026 | Feb 4 2:45 AM | Christopher Cline | Proposed Sale | 7,242 | $32.12 | $232.6K | — | View → |
| Feb 3, 2026 | Feb 4 2:37 AM | Jula Inrig | Proposed Sale | 6,956 | $32.12 | $223.4K | — | View → |
| Feb 3, 2026 | Feb 4 2:30 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 100,087 | $32.28 | $3.2M | 432,886(D) | View → |
| Feb 3, 2026 | Feb 4 2:30 AM | Jula InrigCHIEF MEDICAL OFFICER | Sale | 6,956 | $32.12 | $223.4K | 107,485(D) | View → |
| Feb 3, 2026 | Feb 4 2:30 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 7,242 | $32.12 | $232.6K | 112,971(D) | View → |
| Feb 3, 2026 | Feb 4 2:30 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Sale | 7,310 | $32.12 | $234.8K | 131,823(D) | View → |
| Feb 3, 2026 | Feb 4 2:30 AM | William E. RoteChief Research Officer | Sale | 12,446 | $32.87 | $409.1K | 109,087(D) | View → |
| Feb 3, 2026 | Feb 4 2:30 AM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Sale | 4,333 | $32.12 | $139.2K | 49,080(D) | View → |
| Feb 3, 2026 | Feb 4 2:30 AM | Elizabeth E ReedChief Legal Officer and GC | Sale | 7,175 | $32.12 | $230.5K | 108,205(D) | View → |
| Feb 3, 2026 | Feb 3 4:38 PM | Dube Eric M | Proposed Sale | 100,087 | $32.87 | $3.3M | — | View → |
| Feb 3, 2026 | Feb 3 3:05 PM | ROTE WILLIAM E. | Proposed Sale | 12,446 | $32.87 | $409.1K | — | View → |
| Jan 27, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 51,865 | $30.10 | $1.6M | 419,173(D) | View → |
| Jan 23, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 8,135 | $30.01 | $244.2K | 419,173(D) | View → |
| Jan 27, 2026 | Jan 27 9:05 PM | Dube Eric M | Proposed Sale | 51,865 | $30.10 | $1.6M | — | View → |
| Jan 23, 2026 | Jan 23 9:14 PM | Dube Eric M | Proposed Sale | 8,135 | $30.01 | $244.2K | — | View → |
| Jan 20, 2026 | Jan 21 9:05 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 10,000 | $27.34 | $273.4K | 90,270(D) | View → |
| Jan 20, 2026 | Jan 20 9:04 PM | ELIZABETH REED | Proposed Sale | 10,000 | $27.34 | $273.4K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 22,500 | — | 22,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 45,000 | — | 45,000(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 1, 2026 | May 4 8:27 PM | Roy D. BaynesDirector | Option Exercise | 9,750 | $6.82 | 9,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | LYONS GARY ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Roy D. BaynesDirector | Option Exercise | 32,750 | $21.38 | 6,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Option Exercise | 15,250 | $22.40 | 19,500(D) | View → |
| Apr 14, 2026 | Apr 16 1:47 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 37,500 | $19.08 | 20,000(D) | View → |
| Apr 6, 2026 | Apr 7 10:17 PM | Roy D. BaynesDirector | Option Exercise | 10,000 | $26.52 | 0(D) | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 60,000 | $15.46 | 0(D) | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $15.46 | 45,000(D) | View → |
| Mar 16, 2026 | Mar 18 8:05 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 10,000(D) | View → |
| Feb 20, 2026 | Feb 24 9:05 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 60,000 | $15.46 | 60,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:10 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 20,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 303,600 | $33.10 | 303,600(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Jula InrigCHIEF MEDICAL OFFICER | Grant/Award | 75,000 | $33.10 | 75,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Grant/Award | 75,000 | $33.10 | 75,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 69,640 | $33.10 | 69,640(D) | View → |